[ Price : $8.95]
FDA proposes to evaluate drugs and categories of drugs that present demonstrable difficulties for compounding and place three cate...[ Price : $8.95]
Two U.S. House lawmakers introduce a bipartisan bill to create an emergency supply of active pharmaceutical ingredients (APIs) use...[ Price : $8.95]
Federal Register notice: FDA withdraws approval of an Air Products and Chemicals NDA and new animal drug application for medical g...[ Price : $8.95]
FDA publishes a guidance to assist in the design and analysis of studies assessing the influence of impaired renal function on an ...[ Price : $8.95]
FDA grants Takeda Pharmaceutical accelerated approval for Iclusig (ponatinib) for use with chemotherapy in adult patients with new...[ Price : $8.95]
FDA accepts for review a Citius Pharmaceuticals BLA resubmission for Lymphir (denileukin diftitox), an interleukin-2-based immunot...[ Price : $8.95]
A bipartisan group of nine senators asks the Defense Department for an update on its efforts to secure the military pharmaceutical...[ Price : $8.95]
Two stakeholders make suggestions to revise an FDA draft guidance on its new drug advanced manufacturing technology designation pr...